Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 46301-46350 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05557695
Observational Study of Acalabrutinib in Patients With Chronic Lymphocytic Leukaemia in the United Kingdom
N/ARecruiting
350 participants
Started: Oct 17, 2022 · Completed: Apr 1, 2027
1 condition2 sponsors29 locations
NCT06297785
Online, Gut-directed Hypnotherapy for Patients With Irritable Bowel Syndrome (IBS)
NARecruiting
50 participants
Started: Oct 17, 2022 · Completed: Apr 30, 2027
1 condition1 sponsor2 locations
NCT04743791
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
PHASE4Recruiting
30 participants
Started: Oct 17, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT05591820
A Randomized Controlled Trial on Brief Behavioral Parent Training
NARecruiting
93 participants
Started: Oct 17, 2022 · Completed: Dec 31, 2026
6 conditions1 sponsor1 location
NCT05304065
Youth Partners in Care for Suicide Prevention
PHASE2Recruiting
1,600 participants
Started: Oct 17, 2022 · Completed: Dec 31, 2026
1 condition7 sponsors5 locations
NCT06217224
Evaluation of Prophylactic Photobiomodulation Therapy in Patients With Osteosarcoma
NARecruiting
53 participants
Started: Oct 17, 2022 · Completed: Jul 30, 2025
1 condition1 sponsor1 location
NCT05467150
Maternal Probiotic Supplementation for Improved Outcomes in Infants of Diabetic Mothers
NARecruiting
60 participants
Started: Oct 17, 2022 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT05312827
Training Intervention and Program of Support (TIPS): Fostering Family-centred Telehealth in Pediatric Rehabilitation
NARecruiting
2,360 participants
Started: Oct 17, 2022 · Completed: Oct 31, 2027
1 condition2 sponsors3 locations
NCT05354778
HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP Study
NARecruiting
180 participants
Started: Oct 16, 2022 · Completed: Jul 31, 2024
2 conditions4 sponsors1 location
NCT05573282
Observation Study of Sequential Regorafenib Plus ICIs After HAIC for Advanced Hepatocellular Carcinoma
N/ARecruiting
50 participants
Started: Oct 16, 2022 · Completed: Jan 1, 2026
1 condition1 sponsor2 locations
NCT05631405
Efficacy of Dengue Infection With Warning Signs Treated With Dexamethasone (DengDex Study)
NARecruiting
200 participants
Started: Oct 16, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations
NCT05445037
Hemodynamic and Cerebral Effects Evaluation in Anesthesia
NARecruiting
100 participants
Started: Oct 16, 2022 · Completed: Jul 1, 2024
2 conditions1 sponsor1 location
NCT05629559
4D-310 in Adults With Fabry Disease and Cardiac Involvement
PHASE1/PHASE2Recruiting
18 participants
Started: Oct 16, 2022 · Completed: Jun 30, 2030
1 condition1 sponsor4 locations
NCT05459935
Photobiomodulation for Pediatric Hypertrophic Tonsils
NARecruiting
64 participants
Started: Oct 15, 2022 · Completed: Jan 6, 2030
3 conditions1 sponsor1 location
NCT05381597
5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer
PHASE2/PHASE3Recruiting
200 participants
Started: Oct 15, 2022 · Completed: Jun 30, 2027
2 conditions1 sponsor1 location
NCT05429099
Mandibular Reconstruction Preplanning (ViPMR)
PHASE2/PHASE3Recruiting
420 participants
Started: Oct 15, 2022 · Completed: Oct 15, 2026
2 conditions1 sponsor1 location
NCT05538338
Platelet Rich Plasma for Insufficient Endometrium
NARecruiting
62 participants
Started: Oct 15, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05255159
Lesion-to-lesion Comparison of 68Ga-HA-DOTATATE, 18F-DOPA, and 18F-FDG PET/CT in the Evaluation of Metastatic Neuroendocrine Tumors
PHASE2Recruiting
50 participants
Started: Oct 15, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT03621904
PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer
N/ARecruiting
150 participants
Started: Oct 15, 2022 · Completed: Sep 1, 2027
3 conditions15 sponsors1 location
NCT05570136
Functional Exercise for Sarcopenia
NARecruiting
60 participants
Started: Oct 15, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor7 locations
NCT04452500
Phase IIa Trial of a Selective Glucocorticoid Receptor Antagonist in the Treatment of Veterans With Posttraumatic Stress Disorder (PTSD) (Seven Study)
PHASE2Recruiting
88 participants
Started: Oct 15, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT05575323
Randomized Trial on Same-day SBRT and Surgical Stabilization for Symptomatic Spinal Metastases
NARecruiting
100 participants
Started: Oct 15, 2022 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT05536856
Topical 5-Fluorouracil Effervescent Powder in the Treatment of Vitiligo
PHASE4Recruiting
60 participants
Started: Oct 15, 2022 · Completed: Oct 30, 2024
3 conditions1 sponsor1 location
NCT05692726
Evaluation of Volume and Electrolyte Balance in Hyponatremia Treatment - a Prospective Observational Trial
N/ARecruiting
50 participants
Started: Oct 15, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT05384223
Evaluation of RRFT for Co-occurring SUD and PTSD Among Teens
NARecruiting
212 participants
Started: Oct 15, 2022 · Completed: Jun 30, 2026
2 conditions4 sponsors2 locations
NCT04909138
Intermittent Dosing of Dorsal Root Ganglion Stimulation as an Alternate Paradigm to Continuous Low-Frequency Therapy
NARecruiting
30 participants
Started: Oct 15, 2022 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT04787198
Investigating Composite Biomarkers for Pain Catastrophizing
NARecruiting
44 participants
Started: Oct 15, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05293769
Reliability of a Food Frequency Questionnaire in the Assessment of Dietary Intake Including FODMAPs in Different Populations, and Relationship with IBS Symptoms and the Degree of Self-assessed Physical Activity
N/ARecruiting
400 participants
Started: Oct 15, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05550714
Choice of Anesthesia in Microelectrode Recording Guided Deep Brain Stimulation for Parkinson's Disease
NARecruiting
188 participants
Started: Oct 15, 2022 · Completed: Sep 30, 2024
4 conditions1 sponsor1 location
NCT05261321
Cannabis and Polysubstance Use: Response Inhibition and Stress Exposure
PHASE1Recruiting
20 participants
Started: Oct 15, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05424783
MRI And GPS Informing Choices for Prostate Cancer Treatment (MAGIC)
N/ARecruiting
222 participants
Started: Oct 15, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors2 locations
NCT05931328
The Study of the Combination of Thiotepa and Pomalidomide for the Treatment of Relapsed/Refractory Primary Central Nervous System Lymphoma Patients.
PHASE2Recruiting
28 participants
Started: Oct 15, 2022 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT03887481
Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Logopenic Variant PPA
NARecruiting
60 participants
Started: Oct 15, 2022 · Completed: Oct 31, 2027
2 conditions2 sponsors1 location
NCT04705467
3DUS Imaging of Needles in Gynecological Brachytherapy
NARecruiting
35 participants
Started: Oct 15, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06530264
Evaluation of Different Methods of Posterior Flap Management in External Dacryocystorhinostomy
NARecruiting
100 participants
Started: Oct 15, 2022 · Completed: Oct 15, 2024
1 condition1 sponsor1 location
NCT05532982
Parkinson's Disease in Asian Americans
N/ARecruiting
430 participants
Started: Oct 15, 2022 · Completed: Nov 30, 2024
1 condition2 sponsors1 location
NCT06789458
Assessment of Pro-Resolution Mediator Levels in Periodontitis Stage III and IV Before and After Periodontal Therapy
NARecruiting
22 participants
Started: Oct 15, 2022 · Completed: Oct 14, 2025
1 condition1 sponsor2 locations
NCT06501261
CALM Psychotherapy in Patients With Metastatic Cancer in Chile
NARecruiting
34 participants
Started: Oct 14, 2022 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT05454280
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
PHASE3Recruiting
880 participants
Started: Oct 14, 2022 · Completed: Nov 1, 2028
2 conditions1 sponsor1 location
NCT05623904
Carotid Revascularization Versus Best Medical Treatment for Asymptomatic Carotid Stenosis
NARecruiting
1,056 participants
Started: Oct 14, 2022 · Completed: Dec 31, 2025
4 conditions11 sponsors11 locations
NCT04964206
Neuraxial Labor Analgesia and Offspring Neurodevelopment
N/ARecruiting
5,580 participants
Started: Oct 14, 2022 · Completed: Dec 31, 2028
5 conditions2 sponsors2 locations
NCT05929352
Song-making In a Group (SING)
NARecruiting
200 participants
Started: Oct 14, 2022 · Completed: May 31, 2026
1 condition2 sponsors1 location
NCT05633303
Personalised Ablation Strategies in AF
NARecruiting
160 participants
Started: Oct 14, 2022 · Completed: Oct 10, 2027
1 condition1 sponsor1 location
NCT05572957
LBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBB
NARecruiting
50 participants
Started: Oct 14, 2022 · Completed: Dec 31, 2026
3 conditions6 sponsors6 locations
NCT05472389
Neurodevelopmental Impact of Epilepsy on Autonomic Function in Dravet Syndrome
NARecruiting
100 participants
Started: Oct 14, 2022 · Completed: Jun 14, 2026
2 conditions1 sponsor4 locations
NCT05053867
A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients
PHASE3Recruiting
60 participants
Started: Oct 14, 2022 · Completed: Jul 31, 2027
2 conditions1 sponsor1 location
NCT05360160
A Phase I-II Study Investigating the All-Oral Combination of the Menin Inhibitor SNDX-5613 With Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE)
PHASE1/PHASE2Recruiting
43 participants
Started: Oct 14, 2022 · Completed: Dec 1, 2026
1 condition3 sponsors1 location
NCT05340881
Systematic Light Exposure in Pediatric Brain Tumor Survivors
NARecruiting
40 participants
Started: Oct 14, 2022 · Completed: Jul 31, 2026
1 condition3 sponsors1 location
NCT06816615
Diagnosis and Percutaneous Treatment of Biliary Tract Diseases
NARecruiting
24 participants
Started: Oct 14, 2022 · Completed: Jan 31, 2027
3 conditions1 sponsor1 location
NCT05470920
Genetic Testing Decision Aid
NARecruiting
350 participants
Started: Oct 14, 2022 · Completed: Dec 31, 2026
2 conditions2 sponsors2 locations